Apotheek Vanheusden financials
A multi-period view of the public annual-account figures reported for Apotheek Vanheusden, with comparable measures and links to available source documents.
Company overviewRegistry number
0439111575
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for Apotheek Vanheusden
2025 versus 2024
- Operating line
- €642,262
- EBITDA
- €508,125
- Total assets
- €2,113,636
- Equity
- €294,757
-6.2%
-14%
-19.3%
+0.5%
EBITDA margin +79.1% · Equity ratio +13.9%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €642,262 | €508,125 | €2,113,636 | €294,757 | - |
| 202431 Dec 2024 | €684,380 | €590,898 | €2,618,391 | €293,367 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.